Intravenous (IV) Hydration Therapy Market Size, Share, Opportunities, And Trends By Type (IV Push, IV Drip), By Medical Applications (IV Vitamin Therapy, Immunity IV Infusion, Weight Loss IV Drip, Pregnancy Symptom Alleviation, Others), By End-user (Hospitals, Others), And By Geography - Forecasts From 2023 To 2028

The intravenous (IV) hydration therapy market is projected to show steady growth during the forecast period.

IV hydration therapy is a medical procedure designed to administer fluids directly into the bloodstream through a vein, offering a faster and more efficient means of hydration compared to traditional fluid intake. Common applications of IV hydration therapy include addressing dehydration, which may result from vomiting, diarrhea, fever, excessive sweating, or insufficient fluid intake. Additionally, the therapy is employed to manage electrolyte imbalances, correcting disparities in essential minerals like sodium, potassium, and magnesium. Such imbalances can arise from conditions like dehydration, certain medications, or other medical issues.

The market offers a diverse array of products, including essential IV Fluids, Colloid Solutions for prolonged hydration, IV Sets ensuring precise administration, and Infusion Pumps for controlled delivery. Accessories, such as catheters and dressings, further enhance the safety and effectiveness of intravenous therapy. This comprehensive range caters to varied medical needs, enabling healthcare professionals to tailor treatments for conditions like dehydration and electrolyte imbalances. The market's dynamic nature reflects ongoing advancements, providing versatile solutions for intravenous hydration across diverse healthcare applications.

Market Drivers

• Technological advancements

The future of IV therapy looks promising, with ongoing technological innovations poised to transform this once hospital-centric treatment into a personalized and accessible option for a broader range of patients and medical conditions. In March 2023, a team of undergraduate students at the University of Washington designed a cost-effective IV monitor specifically for newborn care, addressing the needs of low- and middle-income countries. Dr. Gregory Valentine from the UW School of Medicine's Department of Pediatrics led the initiative. Similarly, in August 2023, Sencilia, a startup based in Groningen, is working on an IV flow monitoring system to mitigate intravenous dosage errors and enhance fluid balance accuracy. Their development includes a small, highly sensitive sensor designed for low flow rates typical in critical care IV infusions. These sensors can be seamlessly integrated into existing infusion equipment without disrupting established clinical workflows. These significant advancements are propelling the growth of the IV market, contributing to overall improvements in the healthcare sector.

• Growing geriatric population

The global increase in the elderly population, combined with demographic shifts, is driving the demand for healthcare services and IV hydration therapy. In India, there has been a steady rise in the elderly population, accounting for 8.6% of the total population above the age of 60 as per the 2011 census. Projections indicate this figure is expected to surpass 10% by 2020. The decadal growth rate of the elderly population between the 2001 and 2011 censuses marked an increase for the first time since independence.

In the United States, the population aged 65 and over has notably expanded, reaching 55.8 million or 16.8% of the total population in 2020. This demographic shift signifies an aging population, correlating with a higher prevalence of health conditions that may necessitate medical intervention, including the utilization of IV hydration services. In Europe, the dependency ratio, measuring the number of elderly individuals in the working-age population, is projected to rise significantly by 2100. This points towards a larger proportion of elderly individuals who may require healthcare services. As the aging population grows, there is an expected increase in the demand for healthcare services, with IV services, including home delivery, becoming progressively crucial in addressing prevalent conditions associated with older age.

Market Challenges

• Public perception regarding IV therapy

Public perception plays a crucial role in shaping the acceptance and adoption of medical treatments, including IV therapy. Misconceptions surrounding IV therapy being viewed as a "luxury" treatment or its unnecessary use in healthy individuals can indeed create negative public perception, potentially hindering market growth. While IV therapy does have legitimate medical uses and benefits, the portrayal of it as a trendy or luxurious lifestyle choice might lead to the misconception that it is only for the affluent or those seeking extravagant experiences. This perception can contribute to skepticism among the general public, leading them to view IV therapy as unnecessary or only suitable for individuals with disposable income pursuing non-essential treatments.

The market for intravenous (IV) hydration therapy is segmented into- IV Push and IV Drip.

The market for intravenous (IV) hydration therapy is categorized into two main segments: IV Push and IV Drip. IV Push entails rapidly injecting a small volume of fluid directly into the vein using a syringe or specialized pump. This method is designed to deliver fluids swiftly, with the substance often reaching the bloodstream promptly. Examples include treating electrolyte imbalances, managing anaphylaxis, or administering specific medications like antibiotics. On the other hand, IV Drip involves the continuous infusion of fluids into the vein through a catheter and tubing system. This method is well-suited for sustained hydration needs, making it ideal for treating conditions such as dehydration, replenishing electrolytes, or providing long-term nutritional support.

APAC is anticipated to hold a significant share of the IV hydration market

Collaborative efforts to advance healthcare infrastructure are anticipated to drive the expansion of both the overall healthcare sector and the IV intravenous hydration market in the APAC region. In India, the Union Budget for 2023-24 earmarks Rs. 89,155 crore (US$ 10.76 billion) for the Ministry of Health and Family Welfare, reflecting a 3.43% increase from the previous year. Notable allocations include Rs. 3,365 crore (US$ 0.41 billion) for the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) and Rs. 6,500 crore (US$ 780 million) for Human Resources for Health and Medical Education. China's healthcare sector has experienced significant growth, boasting over a million healthcare institutions established by the end of 2021. This comprises 36,570 hospitals and 977,790 primary-level clinics, organized into a three-tier system based on their capabilities in medical care, education, and research. While Japan leads in the number of hospital beds per population, Sri Lanka, with average bed availability, records the highest discharge rate. While, Japan, the Republic of Korea, and Korea DPR surpass one bed per 100 population, whereas Bangladesh, Pakistan, and Cambodia fall below one bed per 1,000 population, indicating a potential demand for home IV services in these regions.

Market Developments

• December 2023 -   In Sacramento, CA,  IV DRIPS Customized IV Hydration & Wellness expanded its premier mobile intravenous therapy service into the area. Dedicated to enhancing health and well-being, IV DRIPS now offers on-demand, in-home drips through a concierge service. Clients in Sacramento and its vicinity can benefit from proprietary IV infusion blends containing essential fluids, electrolytes, vitamins, and antioxidants.
• September 2023 - Prime IV Hydration & Wellness announced a statewide expansion in Florida, solidifying its position as the nation's leading vitamin infusion therapy franchise. Throughout the year, the franchise strategically developed its presence in key markets across the country, responding to the escalating consumer interest in IV treatments. Florida had become the latest focus of substantial buildout, with 19 franchise locations in various stages of development statewide.
• August 2023 -. Apex Labs CBD  announced its entry into a novel frontier in cannabinoid delivery methods—intravenous (IV) therapy—by introducing a groundbreaking solution with patent-pending technology designed for IV use. The crucial aspect enabling the use of cannabinoids through IV treatment involved the reduction in the size of the CBD molecule.

Company Products

• PlumSet IV Tubing.- LifeShield offers the Primary PlumSet IV Tubing, featuring several key attributes. This tubing is equipped with a Clave-Y-Site, enhancing its versatility and ease of use in medical settings. With a 15-milliliter drip rate, it provides precise and controlled fluid administration during intravenous procedures. The tubing is constructed with polyethylene lining, ensuring its durability and reliability in delivering fluids.
• B. Braun - B. Braun offers Sterile Water for Injection USP in convenient and sterile bags with volumes of 250ml, 500ml, and 1000ml. This sterile water is a clear, colorless, and odorless liquid, ensuring its purity and quality. It meets the standards of the United States Pharmacopeia (USP) and is free from bacteriostatic or antimicrobial agents.
• B-Lean IV Kit - One specific application of IV nutritional therapy is the B-Lean IV kit, designed to aid in fat-burning and metabolism enhancement. This kit consists of six treatments featuring premium-quality compounds, primarily leveraging the advantages of B vitamins. Beyond physical benefits, the B-Lean IV kit has been associated with improvements in overall mood. The inclusion of B vitamins in the treatment contributes to mood enhancement, promoting a sense of well-being and vitality.

Market Segmentation

• By Type
  • IV Push
  • IV Drip
• By medical applications
  • IV Vitamin Therapy
  • Immunity IV Infusion
  • Weight Loss IV Drip
  • Pregnancy Symptom Alleviation
  • Others
• By End-user
  • Hospitals
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Indonesia
    • Thailand
    • Others